Ranbaxy Laboratories: taking advantage of generic opportunities in … - Pharmaceutical Business Review
Ranbaxy Laboratories: taking advantage of generic opportunities in …Pharmaceutical Business Review - 17 hours agoThe current market leader is the AChEI Aricept (donepezil) with 74% of the AChEI market in 2006, which is jointly marketed in the US by Pfizer and Eisai. …
Read full story